Clinical Excellence
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Clinical Excellence
-
Sustainability Snapshot: An Update on DaVita’s Renewable Energy Journey
In April 2019, DaVita committed to a goal of being 100% powered by renewable energy by 2022.
-
DaVita Integrated Kidney Care Achieves Three-Year NCQA Population Health Program Accreditation
DaVita IKC’s patient-centered approach helps the organization achieve the Triple Aim—to improve the patient experience of care, improve the health of populations, and to reduce the per capita cost of health care. This has led DaVita IKC to this top performer recognition as an NCQA-accredited provider.
-
Personalized Care Helps Texan with Kidney Disease Live Life to the Fullest
DaVita IKC works with health insurers, providers and health systems to give comprehensive care to people in various stages of kidney disease.
-
Bringing Dialysis Treatment Home
Home dialysis isn’t new, but recent policy shifts, investments and technological advancements have accelerated patient adoption rates to record levels.
-
Nephrology Nurses: A Lifeline for Patients & the Kidney Care Sector
Nephrology Nurses: A Lifeline for Patients & the Kidney Care Sector
